Common Names

  • L-Glutamine
  • GLN

For Patients & Caregivers

Glutamine may be helpful for preventing some symptoms related to cancer treatments, such as oral inflammation. Combined with other nutrients, it can prevent muscle wasting and weight loss in patients with advanced cancer and HIV, but more research is needed.

Glutamine is the most abundant amino acid in the human body. It is made by most body tissues and is also found in foods such as wheat, corn, barley, peanuts, soybeans, and milk. Glutamine is important for several bodily functions, like acting as building blocks for protein. When the body is malnourished or breaks down its own muscle protein, known as cachexia, taking extra glutamine can help restore body levels and prevent adverse health effects. For example, glutamine is the major fuel source of cells that line the intestinal tract, and is therefore important in maintaining GI function. It is also the major fuel source for certain cells used in the body’s immune defense. It removes excess toxic ammonia from the body and synthesizes glutathione to help detoxify foreign substances in the liver.

Glutamine may help treat muscle wasting in patients with advanced cancer and AIDS and prevent oral inflammation related to certain cancer treatments. Initial studies also suggest it may help chemotherapy-related nerve pain. Larger well-designed trials are needed to confirm these effects.

  • To prevent cachexia (muscle wasting) in advanced cancer and AIDS
    Preliminary results from clinical trials show that a combination of glutamine, arginine, and beta-hydroxy-beta-methylbutyrate (Juven®) can promote weight gain in these patients, but the long-term effectiveness is not known.
  • To prevent mucositis caused by cancer-related treatments
    Several studies suggest that oral glutamine supplementation may be helpful as supportive care for inflammation of oral mucous membranes caused by cancer treatment. Larger confirmatory trials are needed.
  • To reduce chemotherapy-induced gastrointestinal toxicity
    One study showed that glutamine given intravenously to patients receiving chemotherapy for gastric or colorectal cancer significantly reduced nausea, vomiting, and diarrhea.
  • To treat chemotherapy-related neuropathy
    Preliminary studies suggest that glutamine may help treat neuropathy caused by chemotherapy. Larger confirmatory trials are needed.
  • To improve tissue integrity
    Clinical research supports the use of intravenous glutamine to enhance the integrity of the intestines in critically ill patients.
  • To stimulate the immune system
    Although glutamine is a necessary fuel source for lymphocytes, a type of immune cell, there is no solid evidence that glutamine supplements can stimulate the immune system in healthy people. In some studies, intravenous glutamine helps improve immune status, prevent infection, and prevent depletion of intestinal immune cells in critically ill patients and those recovering from surgery.
  • Intravenously, to improve recovery from surgery
    Several clinical trials support this use.

Studies in cancer patients suggest oral glutamine is well tolerated. However, other studies using specific oral preparations reported adverse events including swelling, gastrointestinal symptoms, heachache, fever, and infections.

Although related, glutamine should not be confused with another amino acid known as glutamate.

Back to top

For Healthcare Professionals

Glutamine is an amino acid that can be absorbed from food sources and synthesized and stored, mainly in the muscle and the lungs. It is the building block of protein and a major cellular fuel source. Although abundant in the body, patients with cancer and HIV/AIDS-related cachexia or recovering from catabolic states such as surgery, sepsis, and intense exercise may need to increase intake. Parenteral supplementations are used in hospitals but oral formulations are available in medical foods. Glutamine is also marketed as a dietary supplement to enhance muscle building, wound healing, and for intestinal and immune system health.

Glutamine improves nitrogen balance, preserves intestinal integrity (1) (2), maintains intracellular glutamine levels, and reduces hospital stay in post-surgical or critically ill patients (3) (4), but has no effects on preventing new infections (5). Perioperative intravenous glutamine restored disturbed renal arginine synthesis that occurred from abdominal aortic surgery (6). When used in total parenteral nutrition, glutamine improved nutritional status and reduced mortality and complications (7) (8), but effects on infants with gastrointestinal disease are minimal (9) (10). Among patients with sickle cell anemia, treatment with oral l-glutamine resulted in significantly fewer pain crises (35).

The benefits of glutamine in cancer care have been examined in clinical studies for cachexia (11) (12) (13), peripheral neuropathy (14) (15), mucositis (16) (17) (18) (19), and gastrointestinal toxicity (20). Intravenous glutamine significantly reduced chemotherapy-induced nausea, vomiting, and diarrhea in patients with gastric or colorectal cancer (21). An RCT suggests enteral nutrition that includes arginine , glutamine, and omega-3 fatty acids may improve short-term survival in stage IV gastric cancer patients (22). It was also effective against radiation morbidity in breast cancer patients (23). Conclusions from a meta-analysis indicate glutamine reduces duration but not severity of diarrhea (24). However, conflicting data indicate that perioperative glutamine did not have an influence on post-surgical complications or infection in gastrointestinal cancer patients (25). Furthermore, recent findings suggest a role in tumor cell growth and maintenance (26) (27). More research is needed to resolve the ambiguity.

In an RCT of the glycemic effects of glutamine, modest decreases in concentrations of circulating blood cells, total protein, and albumin were observed (28).

Wheat, corn, barley, peanuts, soybeans, egg whites, and milk

  • Cancer-related cachexia
  • Cancer treatment-related mucositis
  • Chemotherapy-induced neuropathy
  • Chemotherapy-induced gastrointestinal toxicity
  • AIDS-associated wasting
  • Immunostimulation
  • Recovery from surgery

Glutamine is essential for the maintenance of intestinal mucosal integrity and function (1). It maintains immune function by serving as the principle metabolic fuel for cells, acts as a precursor for protein synthesis, and along with cysteine and glycine, is involved in glutathione (GSH) synthesis. Intravenous glutamine preserves liver and intestinal glutathione stores in animal models of oxidant damage. Glutamine is also involved in nitrogen exchange, as it neutralizes and eliminates excess ammonia formed during protein catabolism. As a nitrogen donor, it contributes to the synthesis of other non-essential amino acids, including the purines and pyrimidines, and is therefore essential for the proliferation of most cells (29). It also plays a supportive role during biochemical stress and sepsis. Reduced oxidative stress and sickle cell-related pain with l-glutamine is attributed to increased proportions of the reduced form of nicotinamide adenine dinucleotides in sickle cell erythrocytes (35).

Although the mechanism in treatment of cachexia is unclear, it is thought that glutamine, a modulator of protein turnover, enhances net protein synthesis (11). Clinical evidence suggests that total parenteral nutrition supplemented with glutamine improves nitrogen balance, maintains the intracellular glutamine pool, enhances protein synthesis, and prevents deterioration of gut permeability in post-surgery patients (12)

Glutamine prevented genotoxic and clastogenic damages caused by cisplatin in mice (30). Glutamine may potentiate the tumoricidal effect of methotrexate (MTX) since polyglutamation of MTX impairs its efflux from tumor cells and may reduce its accumulation in the gut (31). The supplemental intravenous form leads to increases of GSH in the gut, but not in tumors, in a sarcoma-bearing rat model.

However, recent findings show that glutamine transporters are upregulated in tumor cells and that glutamine acts as a mitochondrial substrate and promotes protein translation. This indicates tumor cell dependence for growth and maintenance (26). In addition, a recent study demonstrated that glutamine helps cancer cells survive acidic stress through enzymatic deamidation rather than provide nutrition  (27).

Studies in cancer patients suggest oral glutamine is well tolerated (14) (17) (18) (19). However, other studies using specific oral preparations reported adverse events including peripheral edema, gastrointestinal symptoms, heachache, fever, and infections (32) (33).

Lactulose: Glutamine may reduce the ammonia-lowering effect of lactulose (34). This interaction does not apply when lactulose is used as a laxative.
Methotrexate: Glutamine may preferentially increase tumor retention of MTX, thereby increasing its therapeutic efficacy (31).

  1. van der Hulst RR, van Kreel BK, von Meyenfeldt MF, et al. Glutamine and the preservation of gut integrity. Lancet. May 29 1993;341(8857):1363-1365.

  2. Melis GC, ter Wengel N, Boelens PG, et al. Glutamine: recent developments in research on the clinical significance of glutamine. Curr Opin Clin Nutr Metab Care. Jan 2004;7(1):59-70.

  3. Brinkmann SJ, Buijs N, Vermeulen MA, et al. Perioperative glutamine supplementation restores disturbed renal arginine synthesis after open aortic surgery: a randomized controlled clinical trial. Am J Physiol Renal Physiol. Sep 1 2016;311(3):F567-575.

  4. Liu X, Sun XF, Ge QX. The role of glutamine supplemented total parenteral nutrition (TPN) in severe acute pancreatitis. Eur Rev Med Pharmacol Sci. Oct 2016;20(19):4176-4180.

  5. Asrani V, Chang WK, Dong Z, et al. Glutamine supplementation in acute pancreatitis: a meta-analysis of randomized controlled trials. Pancreatology. Sep-Oct 2013;13(5):468-474.

  6. Wagner JV, Moe-Byrne T, Grover Z, et al. Glutamine supplementation for young infants with severe gastrointestinal disease. Cochrane Database Syst Rev. Jul 11 2012(7):Cd005947.

  7. Griffiths RD, Jones C, Palmer TE. Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutrition. Apr 1997;13(4):295-302.

  8. Sands S, Ladas EJ, Kelly KM, et al. Glutamine for the treatment of vincristine-induced neuropathy in children and adolescents with cancer. Support Care Cancer. Mar 2017;25(3):701-708.

  9. Sayles C, Hickerson SC, Bhat RR, et al. Oral Glutamine in Preventing Treatment-Related Mucositis in Adult Patients With Cancer: A Systematic Review. Nutr Clin Pract. Apr 2016;31(2):171-179.

  10. Rubio I, Suva LJ, Todorova V, et al. Oral glutamine reduces radiation morbidity in breast conservation surgery. JPEN J Parenter Enteral Nutr. Sep 2013;37(5):623-630.

  11. Sun J, Wang H, Hu H. Glutamine for chemotherapy induced diarrhea: a meta-analysis. Asia Pac J Clin Nutr. 2012;21(3):380-385.

  12. Wise DR, Thompson CB. Glutamine addiction: a new therapeutic target in cancer. Trends Biochem Sci. Aug 2010;35(8):427-433.

  13. Huang W, Choi W, Chen Y, et al. A proposed role for glutamine in cancer cell growth through acid resistance. Cell Res. May 2013;23(5):724-727.

  14. Miller AL. Therapeutic considerations of L-glutamine: a review of the literature. Altern Med Rev. Aug 1999;4(4):239-248.

  15. Oliveira RJ, Sassaki ES, Monreal AC, et al. Pre-treatment with glutamine reduces genetic damage due to cancer treatment with cisplatin. Genet Mol Res. Dec 2 2013;12(4):6040-6051.

  16. Rubio IT, Cao Y, Hutchins LF, et al. Effect of glutamine on methotrexate efficacy and toxicity. Ann Surg. May 1998;227(5):772-778; discussion 778-780.

  17. Prescribing information. ENDARI (L-glutamine oral powder). Revised: 7/2017. Accessed December 29, 2017.

  18. Prescribing information. NutreStore [L-glutamine powder for oral solution]. Revised: 01/2008. Accessed December 29, 2017.

  19. Wright G, Jalan R. Management of hepatic encephalopathy in patients with cirrhosis. Best Pract Res Clin Gastroenterol. 2007;21(1):95-110.

  20. Niihara Y, Miller ST, Kanter J, et al. A Phase 3 Trial of l-Glutamine in Sickle Cell Disease. N Engl J Med. Jul 19 2018;379(3):226-235.

Back to top
Back to top

Last Updated